August 1, 2024

Total revenue increased 14% to $129.0 million

Net income of $7.7 million at a 6% margin; adjusted EBITDA increased to $46.2 million at a 36% margin 

Raises full year financial guidance on positive second quarter results and strong second half outlook

NEW YORK, Aug. 1, 2024 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the second quarter ended June 30, 2024.

"We are excited to report double-digit revenue growth in all of our businesses in the second quarter reflecting strong customer adoption of our leading AI-backed products across formats and channels," said Lisa Utzschneider, CEO of IAS. "Measurement revenue grew 17% with a 34% increase in social media revenue, optimization revenue increased 11%, and publisher revenue increased 12%. IAS is leading the way with trust, transparency, and innovation to provide actionable results and superior returns for global marketers. We are raising our full year outlook and remain focused on delivering sustainable, profitable growth."

Second Quarter 2024 Financial Highlights

  • Total revenue was $129.0 million, a 14% increase compared to $113.7 million in the prior-year period.
  • Optimization revenue was $58.5 million, an 11% increase compared to $52.8 million in the prior-year period.
  • Measurement revenue was $52.7 million, a 17% increase compared to $44.9 million in the prior-year period.
  • Publisher revenue was $17.8 million, a 12% increase compared to $15.9 million in the prior-year period.
  • International revenue, excluding the Americas, was $40.1 million, a 16% increase compared to $34.7 million in the prior-year period, or 31% of total revenue for the second quarter of 2024.
  • Gross profit was $101.9 million, a 13% increase compared to $89.8 million in the prior-year period. Gross profit margin was 79% for the second quarter of 2024.
  • Net income was $7.7 million, or $0.05 per share, unchanged from the prior-year period. Net income margin was 6% for the second quarter of 2024. Net income for the second quarter of 2023 includes $23.5 million of stock-based compensation expense related to return-target options as well as an income tax benefit of $29.1 million in the period.
  • Adjusted EBITDA* increased to $46.2 million, a 24% increase compared to $37.4 million in the prior-year period. Adjusted EBITDA* margin was 36% for the second quarter of 2024.
  • Cash and cash equivalents were $70.6 million at June 30, 2024.

Recent Business Highlights

  • YouTube Brand Safety and Suitability Measurement Expansion – In June, IAS expanded its brand safety and suitability measurement product for YouTube to include reporting for Performance Max and Demand Gen campaigns on Google Ads.
  • Reddit Partnership In June, IAS announced a partnership with Reddit to provide advertisers with the confidence to scale their campaigns across Reddit through IAS's AI-driven Total Media Quality (TMQ) product suite.
  • Pinterest Partnership In June, IAS announced a partnership with Pinterest to provide global advertisers with greater transparency into campaigns across Pinterest's in-app feed through IAS's AI-driven Total Media Quality (TMQ) brand safety product.
  • Amazon Expanded Global Measurement – In May, IAS launched its expanded reporting and insights for Amazon DSP media buys. Through a server-to-server (S2S) integration on Amazon DSP, advertisers will now have access to measurement coverage for campaigns across Amazon custom audiences and Twitch inventory. IAS's solutions available to advertisers in Amazon DSP include viewability, invalid traffic (IVT), and brand safety and suitability.
  • Lunio Partnership In June, IAS teamed up with Lunio in a first-to-market partnership to provide post-click measurement and protection across search, social, and display networks. The partnership builds on IAS's existing ad fraud detection and mitigation capabilities, giving marketers the most comprehensive invalid traffic (IVT) protection in the industry.
  • Sincera Partnership In June, IAS and Sincera announced a multi-year, strategic partnership to enhance AI-driven measurement and optimization solutions to drive omnichannel media quality. The partnership provides IAS with unique metadata to enhance media quality and drive unique solutions across channels including the open web, CTV, in-app, and social.
  • Deepfake Detection Availability – In June, IAS announced availability in Beta testing of the industry's first deepfake measurement offering, enabling advertisers to avoid running adjacent to deepfake content as part of the Global Alliance for Responsible Media (GARM)-defined Brand Safety Floor and Suitability Framework misinformation category.
  • Election Lab Launch – In May, IAS launched the IAS Election Lab which aims to provide strategic guidance and actionable insights for advertisers during the global election season.
  • ISO 27001 Certification – In May, IAS achieved ISO 27001:2022 certification for its Information Security Management System. ISO/IEC 27001 is the global standard for information security management systems.

Financial Outlook

"Our second quarter results further validate our scalable and profitable business model. We are driving top-line growth and investing in strategic growth initiatives while maintaining a strong financial position with an adjusted EBITDA margin of 36%, healthy cash flows, and low debt," said Tania Secor, CFO of IAS. "We are raising our 2024 outlook based on our second quarter performance and our expectations for increased revenue growth in the second half of the year."

IAS is introducing the following financial outlook for the third quarter of 2024 and increasing its full year 2024 revenue and adjusted EBITDA outlook:

Third Quarter Ending September 30, 2024:

  • Total revenue of $137 million to $139 million
  • Adjusted EBITDA* of $48 million to $50 million

Year Ending December 31, 2024:

  • Total revenue of $538 million to $544 million
  • Adjusted EBITDA* of $180 million to $184 million

* See "Supplemental Disclosure Regarding Non-GAAP Financial Information" section herein for an explanation of these measures. IAS is unable to provide a reconciliation for forward-looking guidance of adjusted EBITDA and corresponding margin to net income (loss), the most closely comparable GAAP measures without unreasonable effort, because certain material reconciling items, such as depreciation and amortization, interest expense, income tax expense (benefit) and acquisition, restructuring and integration expenses, cannot be estimated due to factors outside of IAS's control and could have a material impact on the reported results. However, IAS estimates stock-based compensation expense for the third quarter of 2024 in the range of $16 million to $17 million and for the full year 2024 in the range of $63 million to $65 million.

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 


(IN THOUSANDS, EXCEPT SHARE DATA)

June 30, 2024


December 31, 2023

ASSETS




Current assets:




Cash and cash equivalents

$        70,603


$      124,759

Restricted cash

275


54

Accounts receivable, net

75,233


74,609

Unbilled receivables

45,320


46,548

Prepaid expenses and other current assets

38,251


18,959

Total current assets

229,682


264,929

Property and equipment, net

4,076


3,769

Internal use software, net

47,578


40,301

Intangible assets, net

159,825


178,908

Goodwill

674,350


675,282

Operating lease right-of-use assets

21,223


21,668

Deferred tax asset, net

2,438


2,465

Other long-term assets

4,950


4,402

Total assets

$   1,144,122


$   1,191,724

LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




Accounts payable and accrued expenses

$        51,096


$        72,232

Operating lease liability

9,483


9,435

Due to related party


121

Deferred revenue

558


682

Total current liabilities

61,137


82,470

Deferred tax liability, net

16,884


20,367

Long-term debt

93,957


153,725

Operating lease liabilities, non-current

18,397


19,523

Other long-term liabilities

6,171


6,183

Total liabilities

196,546


282,268

Commitments and Contingencies (Note 13)




Stockholders' Equity




Preferred Stock, $0.001 par value, 50,000,000 shares authorized at June 30, 2024; 0 shares
issued and outstanding at June 30, 2024 and December 31, 2023.


Common Stock, $0.001 par value, 500,000,000 shares authorized, 160,786,740 and
158,757,620 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively.

161


159

Additional paid-in-capital

934,194


901,259

Accumulated other comprehensive loss

(2,168)


(916)

Retained earnings

15,389


8,954

Total stockholders' equity

947,576


909,456

Total liabilities and stockholders' equity

$   1,144,122


$   1,191,724

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(UNAUDITED)




Three Months Ended June 30,


Six Months Ended June 30,

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)


2024


2023


2024


2023

Revenue


$       129,005


$       113,651


$       243,535


$       219,743

Operating expenses:









Cost of revenue (excluding depreciation and amortization shown below)


27,094


23,819


53,255


45,501

Sales and marketing


29,572


31,702


61,397


57,962

Technology and development


17,487


21,110


35,465


36,639

General and administrative


24,679


42,339


46,059


63,062

Depreciation and amortization


15,709


13,521


30,789


26,346

Foreign exchange loss (gain), net


315


(631)


1,884


(1,147)

Total operating expenses


114,856


131,860


228,849


228,363

Operating income (loss)


14,149


(18,209)


14,686


(8,620)

Interest expense, net


(1,536)


(3,221)


(3,462)


(6,638)

Net income (loss) before income taxes


12,613


(21,430)


11,224


(15,258)

(Provision) benefit for income taxes


(4,923)


29,107


(4,789)


26,081

Net income


$           7,690


$           7,677


$           6,435


$         10,823

Net income per share - basic and diluted


$             0.05


$             0.05


$             0.04


$             0.07

Weighted average shares outstanding:









Basic


160,502,795


155,425,264


159,954,926


155,267,531

Diluted


163,748,596


162,634,310


164,198,233


160,850,434

Other comprehensive income:









Foreign currency translation adjustments


(193)


(221)


(1,252)


928

Total comprehensive income


$           7,497


$           7,456


$           5,183


$         11,751

 

Stock-Based Compensation 

(UNAUDITED)



Three Months Ended June 30,


Six Months Ended June 30,


(IN THOUSANDS)

2024


2023


2024


2023


Cost of revenue

$               82


$             126


$             206


$             210


Sales and marketing

3,435


8,258


9,173


12,145


Technology and development

4,799


7,362


9,198


10,532


General and administrative

6,688


24,689


12,165


28,854


Total stock-based compensation

$         15,004


$        40,4351


$         30,742


$         51,741

1



1

During the three and six months ended June 30, 2023, with the filing of a "shelf" registration statement on Form S-3, the market condition and the implied performance condition relating to the Return-Target Options were deemed to be probable and the Company recognized $23.5 million of stock-based compensation expense for such options in both the three and six months ended June 30, 2023. This is broken out as follows; $2.1 million of sales and marketing expense, $2.6 million of technology and development expense and $18.8 million of general and administrative expense.

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(UNAUDITED)


Three Months Ended June 30, 2024




Common Stock









(IN THOUSANDS, EXCEPT SHARES)


Shares


Amount


Additional

paid-in

capital


Accumulated
other
comprehensive
loss


Retained
earnings


Total

stockholders'

equity

Balance, March 31, 2024


159,761,454


$               160


$       919,192


$          (1,975)


$            7,699


$       925,076

RSUs and MSUs vested


1,025,286


1





1

Stock-based compensation




15,002




15,002

Foreign currency translation adjustment





(193)



(193)

Net income






7,690


7,690

Balance, June 30, 2024


160,786,740


$               161


$       934,194


$          (2,168)


$         15,389


$       947,576



Six Months Ended June 30, 2024




Common Stock









(IN THOUSANDS, EXCEPT SHARES)


Shares


Amount


Additional

paid-in

capital


Accumulated
other
comprehensive
loss


Retained
earnings


Total

stockholders'

equity

Balance, December 31, 2023


158,757,620


$               159


$       901,259


$             (916)


$            8,954


$       909,456

RSUs and MSUs vested


1,831,832


2





2

Option exercises


44,049



313




313

ESPP purchase


153,239



1,895




1,895

Stock-based compensation




30,727




30,727

Foreign currency translation adjustment





(1,252)



(1,252)

Net income






6,435


6,435

Balance, June 30, 2024


160,786,740


$               161


$       934,194


$          (2,168)


$         15,389


$       947,576



Three Months Ended June 30, 2023




Common Stock









(IN THOUSANDS, EXCEPT SHARES)


Shares


Amount


Additional

paid-in

capital


Accumulated
other
comprehensive
loss


Retained
earnings


Total

stockholders'

equity

Balance, March 31, 2023


154,811,980


$               154


$       824,498


$          (1,750)


$            4,862


$       827,764

RSUs and MSUs vested


1,218,542


2





2

Option exercises


248,553



2,878




2,878

Stock-based compensation




40,114




40,114

Foreign currency translation adjustment





(221)



(221)

Net income






7,677


7,677

Balance, June 30, 2023


156,279,075


$               156


$       867,490


$          (1,971)


$         12,539


$       878,214



Six Months Ended June 30, 2023



Common Stock









(IN THOUSANDS, EXCEPT SHARES)


Shares


Amount


Additional

paid-in

capital


Accumulated
other
comprehensive
loss


Retained
earnings


Total

stockholders'

equity

Balance, December 31, 2022


153,990,128


$               154


$       810,186


$          (2,899)


$               775


$       808,216

RSUs and MSUs vested


1,590,282


2





2

Option exercises


587,502



4,993




4,993

ESPP purchase


111,163



882




882

Stock-based compensation




51,429




51,429

Foreign currency translation adjustment





928



928

Adoption of ASC 326, net of tax






941


941

Net income






10,823


10,823

Balance, June 30, 2023


156,279,075


$               156


$       867,490


$          (1,971)


$         12,539


$       878,214

 

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)  




Six Months Ended June 30,

(IN THOUSANDS)


2024


2023

Cash flows from operating activities:





Net income


$              6,435


$            10,823

Adjustments to reconcile net income to net cash provided by operating activities:





Depreciation and amortization


30,789


26,346

Stock-based compensation


30,742


51,741

Foreign currency loss (gain), net


1,564


(1,239)

Deferred tax benefit


(3,456)


(37,535)

Amortization of debt issuance costs


232


232

Allowance for credit losses


745


1,254

Changes in operating assets and liabilities:





Increase in accounts receivable


(2,070)


(4,483)

Decrease in unbilled receivables


998


2,272

(Increase) decrease in prepaid expenses and other current assets


(19,548)


12,619

(Increase) decrease in operating leases, net


(618)


25

(Increase) decrease in other long-term assets


(557)


4

Decrease in accounts payable and accrued expenses and other long-term liabilities


(20,221)


(10,225)

(Decrease) increase in deferred revenue


(111)


350

Decrease in due to/from related party


(122)


(118)

Net cash provided by operating activities


24,802


52,066

Cash flows from investing activities:





Purchase of property and equipment


(1,323)


(1,810)

Development of internal use software and other


(18,836)


(14,928)

Net cash used in investing activities


(20,159)


(16,738)

Cash flows from financing activities:





Proceeds from the Revolver



75,000

Repayment of long-term debt


(60,000)


(105,000)

Proceeds from exercise of stock options


313


4,993

Cash received from Employee Stock Purchase Program


2,213


1,409

Net cash used in financing activities


(57,474)


(23,598)

Net (decrease) increase in cash, cash equivalents, and restricted cash


(52,831)


11,730

Effect of exchange rate changes on cash, cash equivalents and restricted cash


(1,084)


(142)

Cash, cash equivalents and restricted cash at beginning of period


127,290


89,671

Cash, cash equivalents, and restricted cash, at end of period


$            73,375


$          101,259

Supplemental Disclosures:





Net cash paid during the period for:





Interest


$              3,614


$              5,862

Taxes


$            19,925


$              5,609

Non-cash investing and financing activities:





Property and equipment acquired included in accounts payable


$                 108


$                 140

Internal use software acquired included in accounts payable


$                 661


$              1,159

Lease liabilities arising from right of use assets


$              5,278


$              3,902

 

Supplemental Disclosure Regarding Non-GAAP Financial Information

We use supplemental measures of our performance, which are derived from our consolidated financial information, but which are not presented in our consolidated financial statements prepared in accordance with GAAP. Adjusted EBITDA is the primary financial performance measure used by management to evaluate our business and monitor ongoing results of operations. Adjusted EBITDA is defined as income before depreciation and amortization, stock-based compensation, interest expense, income taxes, acquisition, restructuring and integration costs, foreign exchange gain, net, asset impairments, and other one-time, non-recurring costs. Adjusted EBITDA margin represents the adjusted EBITDA for the applicable period divided by the revenue for that period presented in accordance with GAAP.

We use non-GAAP financial measures to supplement financial information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our shareholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period-to-period comparisons. Although we believe these measures are useful to investors and analysts for the same reasons they are useful to management, as discussed below, these measures are not a substitute for, or superior to, U.S. GAAP financial measures or disclosures. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Reconciliations of historical adjusted EBITDA to its most directly comparable GAAP financial measure, net income/loss, are presented below. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future fiscal periods, we may exclude such items and may incur income and expenses similar to these excluded items.

Reconciliation of Adjusted EBITDA




Three Months Ended June 30,


Six Months Ended June 30,

(IN THOUSANDS, EXCEPT PERCENTAGES)


2024


2023


2024


2023

Net income


$         7,690


$         7,677


$         6,435


$      10,823

Depreciation and amortization


15,709


13,521


30,789


26,346

Stock-based compensation


15,004


40,435


30,742


51,741

Interest expense, net


1,536


3,221


3,462


6,638

Provision (benefit) for income taxes


4,923


(29,107)


4,789


(26,081)

Acquisition, restructuring and integration costs


1,048


809


1,174


1,621

Foreign exchange loss (gain), net


315


(631)


1,884


(1,147)

Asset impairments and other costs



1,469



1,506

Adjusted EBITDA


$       46,225


$       37,394


$       79,275


$      71,447

Revenue


$     129,005


$     113,651


$     243,535


$    219,743

Net income margin


6 %


7 %


3 %


5 %

Adjusted EBITDA margin


36 %


33 %


33 %


33 %

 

Conference Call and Webcast Information
IAS will host a conference call and live webcast to discuss its second quarter 2024 financial results today at 5:00 p.m. ET. To access the live webcast and conference call dial-in, please register under the "News & Events" section of IAS's investor relations website. A replay will be available on IAS's investor relations website following the live call: https://investors.integralads.com

About Integral Ad Science
Integral Ad Science (IAS) is a leading global media measurement and optimization platform that delivers the industry's most actionable data to drive superior results for the world's largest advertisers, publishers, and media platforms. IAS's software provides comprehensive and enriched data that ensures ads are seen by real people in safe and suitable environments, while improving return on ad spend for advertisers and yield for publishers. Our mission is to be the global benchmark for trust and transparency in digital media quality. For more information, visit integralads.com.

Forward-Looking Statements
This earnings press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance, including guidance, and business, including pipeline and industry trends. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate," "estimate," "expect," "project," "plan," "intend," "believe," "may," "will," "should," "can have," "likely," and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected costs, expenditures, cash flows, growth rates and financial results or our plans and objectives for future operations, growth initiatives or strategies, including pursuing business from Oracle or other competitors are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: (i) the adverse effect on our business, operating results, financial condition, and prospects from various macroeconomic factors, including instability in geopolitical or market conditions; (ii) our failure to innovate or make the right investment decisions; (iii) our ability to provide digital or cross-platform analytics; (iv) our failure to maintain or achieve industry accreditation standards; (v) our dependence on integrations with advertising platforms, demand side providers ("DSPs") and proprietary platforms that we do not control; (vi) our ability to compete successfully with our current or future competitors in an intensely competitive market, including with respect to the Oracle opportunity; (vii) our inability to use software licensed from third parties; (viii) our international expansion; (ix) our ability to expand into new channels; (x) our ability to sustain our profitability and revenue growth rate; (xi) risks that our customers do not pay or choose to dispute their invoices; (xii) risks of material changes to revenue share agreements with certain DSPs; (xiii) our dependence on the overall demand for advertising; (xiv) our ability to effectively manage our growth; (xv) the impact that any acquisitions we have completed in the past and may consummate in the future, strategic investments, or alliances may have on our business, financial condition, and results of operations; (xvi) our ability to successfully execute our international plans; (xvii) the risks associated with the seasonality of our market; (xviii) our ability to maintain high impression volumes; (xix) the difficulty in evaluating our future prospects given our short operating history; (xx) uncertainty in how the market for buying digital advertising verification solutions will evolve; (xxi) interruption by man-made problems such as terrorism, computer viruses, or social disruptions; (xxii) the risk of failures in the systems and infrastructure supporting our solutions and operations; (xxiii) our ability to avoid operational, technical, and performance issues with our platform; (xxiv) risks associated with any unauthorized access to user, customer, or inventory and third-party provider data; (xxv) our ability to provide the non-proprietary technology, software, products, and services that we use; (xxvi) the risk that we are sued by third parties for alleged infringement, misappropriation, or other violation of their proprietary rights; (xxvii) our ability to obtain, maintain, protect, or enforce intellectual property and proprietary rights that are important to our business; (xxviii) our involvement in lawsuits to protect or enforce our intellectual property; (xxix) risks that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers; (xxx) risks that our trademarks and trade names are not adequately protected; (xxxi) the impact of unforeseen changes to privacy and data protection laws and regulation on digital advertising; (xxxii) our ability to maintain our corporate culture; (xxxiii) public health outbreaks, epidemics, pandemics, or other public health crises; (xxxiv) risks posed by earthquakes, fires, floods, and other natural catastrophic events; (xxxv) the risk that a perceived failure to comply with laws and industry self-regulation may damage our reputation; and (xxxvi) other factors disclosed in our filings with the SEC. Given these factors, as well as other variables that may affect our operating results, you should not rely on forward-looking statements, assume that past financial performance will be a reliable indicator of future performance, or use historical trends to anticipate results or trends in future periods.

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward- looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Investor Contact:
Jonathan Schaffer
ir@integralads.com 

Media Contact:
press@integralads.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ias-reports-second-quarter-2024-financial-results-302212716.html

SOURCE Integral Ad Science, Inc.